Position in RPRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$240,428
New position
Shares Held
4,288
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#488
of 641 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026West Family Investments, Inc. holds $2,539,425 across 7 Biotechnology names. RPRX ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,695 | $841,957 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,017 | $634,140 | |
| 3 | ARGX |
Argenx SE
|
374 | $346,985 | |
| 4 | INCY |
Incyte Corp
|
2,161 | $244,970 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
4,288 | $240,428 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
767 | $230,890 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
35,500 | $55 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,428 | 4,288 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||